Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CBHB
0339
5
SET
0337
| (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 158.39%3.11M | 493.77%3.91M | 331.68%9.42M | 315.47%5.75M | 136.44%1.8M | -20.48%1.2M | -74.43%658K | -78.14%2.18M | -177.25%-2.67M | -62.85%763K |
| Net profit before non-cash adjustment | 158.72%2.88M | 136.00%2.98M | 47.35%4.95M | 80.11%-199.67K | 344.46%2.77M | -14.20%1.11M | -48.22%1.26M | -61.04%3.36M | -150.68%-1M | -72.70%623K |
| Total adjustment of non-cash items | -27.46%391K | 288.11%269K | 201.76%1.6M | 562.73%2.75M | -667.16%-1.54M | 549.17%539K | -132.72%-143K | -60.65%530.44K | -69.01%414.44K | -47.79%-201K |
| -Depreciation and amortization | -9.95%941K | 67.45%998K | 63.35%3.45M | 87.77%970.02K | 60.31%840K | 97.92%1.05M | 9.56%596K | -14.98%2.11M | -39.91%516.61K | 0.77%524K |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -226.06%-105.1K | -214.07%-95.1K | ---- |
| -Disposal profit | ---- | ---- | -10.84%750K | 184.88%2.5M | ---- | ---- | ---- | 20.17%841.22K | 25.32%877.22K | ---36K |
| -Other non-cash items | -8.70%-550K | 1.35%-729K | -12.17%-2.6M | 18.31%-722.38K | 6.77%-633K | 21.91%-506K | -590.65%-739K | -20.74%-2.32M | -188.99%-884.29K | -3.51%-679K |
| Changes in working capital | 64.88%-157K | 241.47%655K | 268.33%2.87M | 254.06%3.2M | 69.21%577K | -232.25%-447K | -51.80%-463K | -10,383.40%-1.71M | -1,622.30%-2.08M | 470.65%341K |
| -Change in receivables | 51.50%-81K | 134.95%194K | 215.04%2.52M | 245.51%2.88M | 217.25%367K | -279.55%-167K | -490.85%-555K | -1,154.55%-2.19M | -940.14%-1.98M | -9.44%-313K |
| -Change in inventory | -25.00%-95K | 73.33%26K | -159.02%-51.13K | 71.51%110.87K | -304.00%-101K | -300.00%-76K | 66.67%15K | 165.51%86.64K | 239.74%64.64K | 30.56%-25K |
| -Change in payables | 109.31%19K | 464.94%435K | -0.01%399.91K | 229.25%215.91K | -54.20%311K | -159.30%-204K | 116.89%77K | 23.62%399.96K | -218.47%-167.04K | 195.22%679K |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | -59.25%-422K | -7.09%-423K | 25.42%-1.77M | -26.65%-682.6K | 24.51%-428K | 12.25%-265K | 59.11%-395K | 8.89%-2.37M | 54.54%-538.98K | -14.78%-567K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 186.37%2.69M | 1,224.71%3.48M | 4,068.65%7.65M | 257.99%5.07M | 602.04%1.38M | -22.52%939K | -83.63%263K | -102.61%-192.65K | -241.37%-3.21M | -87.44%196K |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -1.61%-693K | 23.19%-775K | -1,055.52%-34M | -5,622.12%-31.61M | 22.58%-703K | 6.70%-682K | -34.35%-1.01M | -22.25%-2.94M | 29.79%-552.34K | -74.62%-908K |
| Net business purchase and sale | --0 | --0 | --0 | --27.28M | --0 | --0 | ---27.28M | --0 | --0 | --0 |
| Net investment property transactions | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---42K | ---2K | --0 |
| Net investment product transactions | -103.39%-200K | -528.95%-26.07M | -116.59%-2.76M | -1,605.34%-3.08M | -90.43%-1.43M | -77.50%5.9M | 52.09%-4.15M | 233.80%16.64M | 98.49%-180.85K | 59.83%-752K |
| Repayment of advance payments to other parties and cash income from loans | ---- | ---- | --32.94K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Dividends received (cash flow from investment activities) | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Interest received (cash flow from investment activities) | -34.77%317K | -6.42%554K | -17.52%2.32M | -31.71%633.64K | -36.28%606K | -15.48%486K | 66.29%592K | 78.57%2.81M | 95.93%927.82K | 176.45%951K |
| Investing cash flow | -110.10%-576K | 17.43%-26.29M | -308.99%-34.41M | -3,601.74%-6.75M | -115.66%-1.53M | -78.08%5.71M | -251.97%-31.84M | 293.21%16.46M | 101.57%192.64K | 64.76%-709K |
| Financing cash flow | ||||||||||
| Net common stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --21.09M | --122 | --0 |
| Increase or decrease of lease financing | -58.82%-54K | -58.82%-54K | -11.95%-152.58K | -47.48%-50.58K | 0.00%-34K | 0.00%-34K | 0.00%-34K | 0.00%-136.3K | 0.00%-34.3K | 0.00%-34K |
| Cash dividends paid | ---- | ---- | 27.28%-3.82M | 296.25%471 | ---- | ---- | ---- | -21.00%-5.26M | ---240 | ---- |
| Financing cash flow | -58.82%-54K | -58.82%-54K | -125.32%-3.98M | -45.60%-50.11K | 27.09%-3.86M | 0.00%-34K | -100.16%-34K | 450.37%15.7M | -0.34%-34.42K | -20.83%-5.29M |
| Net cash flow | ||||||||||
| Beginning cash position | -34.94%40.94M | -32.51%63.81M | 51.09%94.54M | -32.85%65.53M | -32.74%69.54M | -17.40%62.93M | 51.09%94.54M | 12.76%62.57M | 34.38%97.59M | 33.49%103.4M |
| Current changes in cash | -68.85%2.06M | 27.68%-22.86M | -196.15%-30.74M | 43.33%-1.73M | 30.90%-4.01M | -75.70%6.61M | -332.14%-31.61M | 351.49%31.97M | 69.67%-3.05M | -20.14%-5.8M |
| End cash Position | -38.16%43M | -34.94%40.94M | -32.51%63.81M | -32.51%63.81M | -32.85%65.53M | -32.74%69.54M | -17.40%62.93M | 51.09%94.54M | 51.09%94.54M | 34.38%97.59M |
| Free cash flow | 676.65%2M | 463.14%2.71M | -724.67%-26.35M | -605.66%-26.54M | 187.18%673K | -46.57%257K | -187.15%-746K | -164.33%-3.2M | -353.71%-3.76M | -174.23%-772K |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
